A comparative evaluation of management of tuberculosis patients

Abstract

Background: Tuberculosis is still one of the major causes of mortality and morbidity in the world population. The present study was conducted to evaluate different treatment management of tuberculosis patients. Materials & Methods: 46 tuberculosis patients of both genders were divided into 2 groups. Group I comprised of 23 patients who received tab. Isoniazid, rifampicin, pyrazinamide and ethambutol 7 days/ week for 56 doses (8 weeks) and group II also comprised of 23 patients who received tab. Isoniazid, rifampicin and ethambutol 7 days/ week for 56 doses (8 weeks). Treatment outcome in both groups was compared. Results: Group I had 15 males and 8 females and group II had 16 males and 7 females. Smoking was seen in 12 and 10, alcoholism in 4 and 6 and smoking+ alcoholism in 7 and 8. New cases were seen among 10 and 9, relapse cases were 12 and 10 and failure was 1 and 4 in group I and II respectively. Treatment outcome was success cases 17 in group I and 15 in group II. Failed 3 in group I and 5 in group II, died 1 in group I and 2 in group II and lost follow up 2 in group I and 1 in group II. The difference was significant (P< 0.05). Conclusion: Group I patients had less failure cases and high success rate than group II patients.